Compare Cassava Sciences Inc (FLNA) vs Prudential Financial Inc (PRU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Prudential Financial Inc — how do they compare? Cassava Sciences Inc trades at $1.07 (market cap $53.14M), while Prudential Financial Inc trades at $117.49 (market cap $39.96B). The key difference: Prudential Financial Inc is far larger — about 752× Cassava Sciences Inc's market cap, and Prudential Financial Inc pays a 4.87% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | PRU | |
|---|---|---|
Market Cap | $53.14M | $39.96B |
Sector | Health | Financials |
52-Week High | $4.64 | $118.72 |
52-Week Low | $1.09 | $92.00 |
Enterprise Value | -$33.43M | $67.01B |
Dividend Yield | — | 4.87% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Prudential Financial (PRU) trades at $114.79, down 1.19% on the day, with a bullish technical signal from moving averages but neutral oscillators. The stock shows strong fundamentals with a P/E of 11.85 and net income margin of 5.5%, supported by recent earnings beats. Recent news highlights retirement growth and international expansion, while a $1.40 dividend reinforces shareholder returns.
The outlook remains positive given earnings momentum and discounted valuation, though mixed analyst ratings and volatile cash flows pose risks. Upside potential hinges on continued execution in retirement services, while macroeconomic sensitivity and debt levels warrant monitoring for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Prudential Financial Inc
Prudential Financial is a large, diversified insurance company offering annuities, life insurance, retirement plan services, and asset management products. While it operates in a number of countries, the vast majority of revenue is generated in the United States and Japan. The company's investment management business, PGIM, contributes approximately 15% of its earnings and has over $1.5 trillion in assets under management. The U.S. businesses are responsible for about 45% of earnings and can be classified into Institutional Retirement Strategies, Individual Retirement Strategies, Group Insurance, Individual Life Insurance, and Assurance IQ. Finally, the international business segment of the company contributes approximately 40% of earnings with a strong market position in Japan.
Read more on PRU →
